PCVAX | VISVX | PCVAX / VISVX | |
Total Expense Ratio | 1.17 | 0.19 | 616% |
Annual Report Gross Expense Ratio | 1.23 | 0.19 | 647% |
Fund Existence | 29 years | 27 years | - |
Gain YTD | 2.339 | 6.665 | 35% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 268M | 59.2B | 0% |
Annual Yield % from dividends | 1.26 | 1.86 | 68% |
Returns for 1 year | 0.40 | 10.19 | 4% |
Returns for 3 years | -0.03 | 36.58 | -0% |
Returns for 5 years | 13.47 | 86.20 | 16% |
Returns for 10 years | -43.93 | 117.42 | -37% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
ENX | 9.55 | 0.13 | +1.38% |
Eaton Vance New York Municipal | |||
EQAL | 51.99 | 0.21 | +0.41% |
Invesco Russell 1000 Equal Weight ETF | |||
SPSM | 46.41 | 0.12 | +0.26% |
SPDR® Portfolio S&P 600™ Sm Cap ETF | |||
ITDF | 35.74 | 0.04 | +0.11% |
iShares LifePath Target Date 2050 ETF | |||
SMCY | 14.36 | -0.11 | -0.76% |
YieldMax SMCI Option Income Strategy ETF |